The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Overall survival (OS) analysis from PRIME: Randomized phase III study of panitumumab (pmab) with FOLFOX4 for first-line metastatic colorectal cancer (mCRC).
Jean-Yves Douillard
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Salvatore Siena
Consultant or Advisory Role - Amgen; Bayer; Celgene; Genomic Health; Roche; Sanofi
Josep Tabernero
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; ImClone Systems; Lilly; Merck KGaA
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi
Ronald L. Burkes
Consultant or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Sanofi
Honoraria - Amgen; Biogen Idec; Boehringer Ingelheim; Lilly; Roche; Sanofi
Mario Edmundo Barugel
Consultant or Advisory Role - Roche
Honoraria - Amgen; Roche
Yves Humblet
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Gyorgy Bodoky
Consultant or Advisory Role - Amgen
David Cunningham
Employment or Leadership Position - Royal Marsden NHS Foundation Trust
Research Funding - Amgen; Celgene; Merck Serono; Novartis; Roche; Sanofi
Jacek Jassem
No relevant relationships to disclose
Fernando Rivera
Research Funding - Amgen
Ilona Kocáková
No relevant relationships to disclose
Paul Ruff
Research Funding - Amgen
Other Remuneration - Amgen
Martin Smakal
No relevant relationships to disclose
Jean-Luc Canon
Research Funding - Amgen
Mark Rother
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Kelly S. Oliner
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ying Tian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Roger Sidhu
Employment or Leadership Position - Amgen
Stock Ownership - Amgen